Research Article

[Retracted] mRNA-Modified FUS/NRF2 Signalling Inhibits Ferroptosis and Promotes Prostate Cancer Growth

Figure 1

FUS expression and prognosis in patients with PRAD. (a) Expression of normal tissue FUS in PRAD patients. (b) FUS expression and survival rate. (c) Relationship between FUS expression and P53 activation.
(a)
(b)
(c)